{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:37:54Z","timestamp":1792460274656,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Metabolomics is the study of small molecules to simultaneously identify multiple low molecular weight molecules in a system. Broadly speaking, metabolomics can be subdivided into targeted and untargeted types of analysis, each type having advantages and drawbacks. Targeted metabolomics can quantify analytes but only looks for known or expected analytes related to particular disease(s), whereas untargeted metabolomics is typically nonquantitative but can detect thousands of analytes from an agnostic or nonhypothesis driven perspective, allowing for novel discoveries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Content<\/jats:title><jats:p>One application of metabolomics is the study of inborn errors of metabolism (IEM). The biochemical hallmark of IEMs is decreased concentrations of analytes distal to the enzymatic defect and buildup of analytes proximal to the defect. Metabolomics can detect these changes with one test and is effective in screening for and diagnosis of IEMs. Metabolomics has also been used to study many nonmetabolic diseases such as autism spectrum disorder, various cancers, and multiple congenital anomalies syndromes. Metabolomics has led to the discovery of many novel biomarkers of disease. Recent publications demonstrate how metabolomics can be useful clinically in the diagnosis and management of patients, as well as for research and clinical discovery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Metabolomics has proved to be a useful tool clinically for screening and diagnostic purposes and from a research perspective for the detection of novel biomarkers. In the future, metabolomics will likely become a routine part of the evaluation for many diseases as either a supplementary test or it may simply replace historical analyses that require several individual tests and sample types.<\/jats:p><\/jats:sec>","DOI":"10.1093\/clinchem\/hvab184","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T12:10:35Z","timestamp":1631189435000},"page":"1606-1617","source":"Crossref","is-referenced-by-count":46,"title":["Metabolomics in Clinical Practice: Improving Diagnosis and Informing Management"],"prefix":"10.1093","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-0125","authenticated-orcid":false,"given":"John D","family":"Odom","sequence":"first","affiliation":[{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V Reid","family":"Sutton","sequence":"additional","affiliation":[{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX"},{"name":"Baylor Genetics Laboratory, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"2021120111320877500_hvab184-B1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10545-015-9843-7","article-title":"Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism","volume":"38","author":"Miller","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"2021120111320877500_hvab184-B2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/metabo5020192","article-title":"Systemic metabolomic changes in blood samples of lung cancer patients identified by gas chromatography time-of-flight mass spectrometry","volume":"5","author":"Miyamoto","year":"2015","journal-title":"Metabolites"},{"key":"2021120111320877500_hvab184-B3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fpsyt.2019.00647","article-title":"Untargeted metabolomics for autism spectrum disorders: current status and future directions","volume":"10","author":"Glinton","year":"2019","journal-title":"Front Psychiatry"},{"key":"2021120111320877500_hvab184-B4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jchromb.2008.04.031","article-title":"Analytical strategies for LC-MS-based targeted metabolomics","volume":"871","author":"Lu","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2021120111320877500_hvab184-B5","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"Evans","year":"2009","journal-title":"Anal Chem"},{"key":"2021120111320877500_hvab184-B6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.aca.2018.03.058","article-title":"A targeted metabolomics approach for clinical diagnosis of inborn errors of metabolism","volume":"1025","author":"Jacob","year":"2018","journal-title":"Anal Chim Acta"},{"key":"2021120111320877500_hvab184-B7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","article-title":"Untargeted metabolomics strategies\u2014challenges and emerging directions","volume":"27","author":"Schrimpe-Rutledge","year":"2016","journal-title":"J Am Soc Mass Spectrom"},{"key":"2021120111320877500_hvab184-B8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/ed100697w","article-title":"ChemSpider: an online chemical information resource","volume":"87","author":"Pence","year":"2010","journal-title":"J Chem Educ"},{"key":"2021120111320877500_hvab184-B9","doi-asserted-by":"crossref","first-page":"D801","DOI":"10.1093\/nar\/gks1065","article-title":"HMDB 3.0-The human metabolome database in 2013","volume":"41","author":"Wishart","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2021120111320877500_hvab184-B10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1039\/C4MB00729H","article-title":"Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism","volume":"11","author":"Scolamiero","year":"2015","journal-title":"Mol BioSyst"},{"key":"2021120111320877500_hvab184-B11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/gim.2018.45","article-title":"ACMG TECHNICAL STANDARD Laboratory analysis of organic acids, 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Gallagher","year":"2018","journal-title":"Genet Med"},{"key":"2021120111320877500_hvab184-B12","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/ijms21041195","article-title":"Metabolomics to improve the diagnostic efficiency of inborn errors of metabolism","volume":"21","author":"Mordaunt","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2021120111320877500_hvab184-B13","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41436-020-0827-0","article-title":"Integrated analysis of metabolomic profiling and exome data supplements sequence variant interpretation, classification, and diagnosis","volume":"22","author":"Alaimo","year":"2020","journal-title":"Genet Med"},{"key":"2021120111320877500_hvab184-B14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/s41436-019-0442-0","article-title":"Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders","volume":"21","author":"Burrage","year":"2019","journal-title":"Genet Med"},{"key":"2021120111320877500_hvab184-B15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/infdis\/jiz048","article-title":"Kynurenine is a cerebrospinal fluid biomarker for bacterial and viral central nervous system infections","volume":"220","author":"S\u00fchs","year":"2019","journal-title":"J Infect Dis"},{"key":"2021120111320877500_hvab184-B16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"2021120111320877500_hvab184-B17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1651-2227.1999.tb01157.x","article-title":"Newborn screening with tandem mass spectrometry: 12 months\u2019 experience in NSW Australia","volume":"88","author":"Wiley","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"2021120111320877500_hvab184-B18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/10408363.2013.847896","article-title":"Inborn errors of metabolism and expanded newborn screening: review and update","volume":"50","author":"Mak","year":"2013","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2021120111320877500_hvab184-B19","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta1070","article-title":"Neonatal screening for inborn errors of metabolism: cost, yield and outcome","volume":"1","author":"Pollitt","year":"1997","journal-title":"Health Technol Assess"},{"key":"2021120111320877500_hvab184-B20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10545-017-0131-6","article-title":"Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients","volume":"41","author":"Coene","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"2021120111320877500_hvab184-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo9120289","article-title":"Untargeted metabolomics-based screening method for inborn errors of metabolism using semi-automatic sample preparation with an UHPLC-orbitrap-MS platform","volume":"9","author":"Bonte","year":"2019","journal-title":"Metabolites"},{"key":"2021120111320877500_hvab184-B22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgmr.2016.07.007","article-title":"Diagnosis of adenylosuccinate lyase deficiency by metabolomic profiling in plasma reveals a phenotypic spectrum","volume":"8","author":"Donti","year":"2016","journal-title":"Mol Genet Metab Rep"},{"key":"2021120111320877500_hvab184-B23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2015.04.008","article-title":"Aromatic L-amino acid decarboxylase deficiency diagnosed by clinical metabolomic profiling of plasma","volume":"115","author":"Atwal","year":"2015","journal-title":"Mol Genet Metab"},{"key":"2021120111320877500_hvab184-B24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/8904_2016_568","article-title":"A multiplatform metabolomics approach to characterize plasma levels of phenylalanine and tyrosine in phenylketonuria","volume":"32","author":"Blasco","year":"2017","journal-title":"JIMD Rep"},{"key":"2021120111320877500_hvab184-B25","doi-asserted-by":"crossref","first-page":"8825","DOI":"10.1007\/s00216-015-9041-3","article-title":"A GC\/MS-based metabolomic approach for reliable diagnosis of phenylketonuria","volume":"407","author":"Xiong","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"2021120111320877500_hvab184-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.00394","article-title":"2-Pyrrolidinone and succinimide as clinical screening biomarkers for GABA-transaminase deficiency: anti-seizure medications impact accurate diagnosis","volume":"13","author":"Kennedy","year":"2019","journal-title":"Front Neurosci"},{"key":"2021120111320877500_hvab184-B27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2017.12.009","article-title":"Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profiling","volume":"123","author":"Glinton","year":"2018","journal-title":"Mol Genet Metab"},{"key":"2021120111320877500_hvab184-B28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ymgme.2018.05.001","article-title":"Deoxysphingolipid precursors indicate abnormal sphingolipid metabolism in individuals with primary and secondary disturbances of serine availability","volume":"124","author":"Ferreira","year":"2018","journal-title":"Mol Genet Metab"},{"key":"2021120111320877500_hvab184-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.201809091","article-title":"Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers","volume":"10","author":"Buzkova","year":"2018","journal-title":"EMBO Mol Med"},{"key":"2021120111320877500_hvab184-B30","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136055","article-title":"Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity","volume":"131","author":"Sharma","year":"2021","journal-title":"J Clin Invest"},{"key":"2021120111320877500_hvab184-B31","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/gim.2017.262","article-title":"A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers","volume":"20","author":"Wangler","year":"2018","journal-title":"Genet Med"},{"key":"2021120111320877500_hvab184-B32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol Genet Metab"},{"key":"2021120111320877500_hvab184-B33","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/humu.20339","article-title":"Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene","volume":"27","author":"Yamaguchi","year":"2006","journal-title":"Hum Mutat"},{"key":"2021120111320877500_hvab184-B34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymgmr.2015.09.001","article-title":"A homozygous mutation in PEX16 identified by whole-exome sequencing ending a diagnostic odyssey","volume":"5","author":"Bacino","year":"2015","journal-title":"Mol Genet Metab Rep"},{"key":"2021120111320877500_hvab184-B35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10545-011-9439-9","article-title":"Decreased functional brain connectivity in individuals with early-treated phenylketonuria: evidence from resting state fMRI","volume":"35","author":"Christ","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"2021120111320877500_hvab184-B36","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1073\/pnas.0906039107","article-title":"A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells","volume":"107","author":"Shaham","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021120111320877500_hvab184-B37","doi-asserted-by":"publisher","volume-title":"Diagnostic and statistical manual of mental disorders","edition":"5th ed.).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2021120111320877500_hvab184-B38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.anaerobe.2017.12.007","article-title":"Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders","volume":"49","author":"Kang","year":"2018","journal-title":"Anaerobe"},{"key":"2021120111320877500_hvab184-B39","doi-asserted-by":"crossref","first-page":"e104834","DOI":"10.1371\/journal.pone.0104834","article-title":"Cholesterol metabolism is altered in Rett syndrome: a study on plasma and primary cultured fibroblasts derived from patients","volume":"9","author":"Segatto","year":"2014","journal-title":"PLoS ONE"},{"key":"2021120111320877500_hvab184-B40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/metabo9100221","article-title":"Sphingolipid metabolism perturbations in Rett syndrome","volume":"9","author":"Cappuccio","year":"2019","journal-title":"Metabolites"},{"key":"2021120111320877500_hvab184-B41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/jcr.1925.148","article-title":"The metabolism of carcinoma cells","volume":"9","author":"Warburg","year":"1925","journal-title":"J Cancer Res"},{"key":"2021120111320877500_hvab184-B42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41436-018-0106-5","article-title":"Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma","volume":"21","author":"Richter","year":"2019","journal-title":"Genet Med"},{"key":"2021120111320877500_hvab184-B43","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1164\/rccm.200606-769OC","article-title":"Metabolomics applied to exhaled breath condensate in childhood asthma","volume":"175","author":"Carraro","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120111320877500_hvab184-B44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa1616361","article-title":"NAD deficiency, congenital malformations, and niacin supplementation","volume":"377","author":"Shi","year":"2017","journal-title":"N Engl J Med"},{"key":"2021120111320877500_hvab184-B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo10100382","article-title":"Identification and reproducibility of plasma metabolomic biomarkers of habitual food intake in a US diet validation study","volume":"10","author":"Wang","year":"2020","journal-title":"Metabolites"},{"key":"2021120111320877500_hvab184-B46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2021120111320877500_hvab184-B47","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1039\/C6MB00014B","article-title":"Metabolomics in diabetic complications","volume":"12","author":"Filla","year":"2016","journal-title":"Mol Biosyst"},{"key":"2021120111320877500_hvab184-B48","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3109\/14767058.2010.482618","article-title":"Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery","volume":"23","author":"Romero","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2021120111320877500_hvab184-B49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11306-019-1498-1","article-title":"Thanatometabolomics: introducing NMR-based metabolomics to identify metabolic biomarkers of the time of death","volume":"15","author":"Mora-Ortiz","year":"2019","journal-title":"Metabolomics"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/67\/12\/1606\/41387862\/hvab184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/67\/12\/1606\/41387862\/hvab184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T22:10:46Z","timestamp":1673215846000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/67\/12\/1606\/6387435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,11,24]]},"published-print":{"date-parts":[[2021,11,26]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvab184","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,11,24]]}}}